Your session is about to expire
← Back to Search
Aerobic Exercise + Virtual Reality for Parkinson's Disease
N/A
Recruiting
Research Sponsored by The University of Texas Health Science Center at San Antonio
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Diagnosis of idiopathic PD (ages 18 - 85) in Hoehn and Yahr stages 1 - 3
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 3 weeks
Awards & highlights
Study Summary
This trial will test the feasibility and effects of exercise and VR on motor behavior and neuroplasticity in PD patients. If successful, this could provide new insight into using AE and VR to improve cognition, gait, and neuroplasticity in PD patients.
Who is the study for?
This trial is for people aged 18-85 with Parkinson's Disease in early to mid-stages (stages 1-3) who can think clearly enough (score ≥23 on a mental state exam). It's not for those with other neurological diseases, severe heart/lung conditions, uncontrolled diabetes or blood pressure issues, severe bone weakness, brain surgery for PD, head injuries, seizures/epilepsy, pregnancy or certain medication use.Check my eligibility
What is being tested?
The study tests how aerobic exercise combined with virtual reality affects movement and brain changes in Parkinson's. Participants will do physical exercises while engaging in VR tasks to see if this improves their motor skills and cognitive functions.See study design
What are the potential side effects?
Potential side effects may include fatigue from the exercise and possible discomfort or dizziness from using virtual reality equipment. Since it involves physical activity and technology use, there might be risks of falls or motion sickness.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have Parkinson's disease, aged 18-85, in early to mid-stages.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline to 3 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 3 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Balance
Cognition
Corticomotor excitability
+2 moreSecondary outcome measures
Quality of Life Survey
Trial Design
1Treatment groups
Experimental Treatment
Group I: Combined Aerobic Exercise (AE) and Virtual Reality (VR)-based programExperimental Treatment2 Interventions
Individuals diagnosed with PD will participate in AE and VR.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Virtual Reality
2017
Completed Phase 3
~1630
Find a Location
Who is running the clinical trial?
The University of Texas Health Science Center at San AntonioLead Sponsor
452 Previous Clinical Trials
91,389 Total Patients Enrolled
Texas Physical Therapy AssociationOTHER
5 Previous Clinical Trials
169 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have skull abnormalities, fractures, or often get unexplained headaches.I do not have any cognitive or communication issues that would affect my participation.I have Parkinson's disease, aged 18-85, in early to mid-stages.I do not have severe heart, lung, high blood pressure, diabetes, or severe bone loss conditions.I have had surgery for Parkinson's disease, like deep brain stimulation.I am not taking medication that could affect my brain's activity or increase seizure risk.I have a history of neurological diseases like stroke or multiple sclerosis.
Research Study Groups:
This trial has the following groups:- Group 1: Combined Aerobic Exercise (AE) and Virtual Reality (VR)-based program
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are individuals aged eighty-five or above allowed to participate in this trial?
"This research project is looking for participants aged 18 or older, up to a maximum age of 85."
Answered by AI
Is there still an opportunity to join this scientific experiment?
"According to the clinicaltrials.gov website, this study is actively recruiting participants, having been originally posted on November 1st 2022 and updated most recently on that same date."
Answered by AI
What are the eligibility criteria for taking part in this research project?
"This clinical trial seeks to enlist 25 individuals with idiopathic Parkinson's disease, aged between 18 and 85. Candidates must attain a score of 23 or more on the Mini Mental State Examination and present with Hoehn and Yahr stages 1-3 symptoms."
Answered by AI
How many participants are actively participating in this clinical trial?
"Affirmative. Per the information on clinicaltrials.gov, this research venture is presently recruiting volunteers. This study was made available to the public on November 1st 2022 and has since been updated once; it seeks 25 participants at a single location."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger